Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Retension Pharmaceuticals prices upsized IPO at $12 per share seekingalpha.com